Stay updated on Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' on the webpage has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change likely pertains to the specific criteria required for individuals to participate in the clinical research study mentioned on the webpage.
    Difference
    68%
    Check dated 2024-05-22T07:53:28.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the Estimated Study Completion Date to 2024-05, indicating a potential shift in the timeline for the study related to Sitravatinib and Tislelizumab in patients with Metastatic Uveal Melanoma with Liver Metastases.
    Difference
    0.0%
    Check dated 2024-05-09T02:04:03.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 03 12 03 11 03 12 to 05 07 Valencia, Spain, 46014 Hospital General Universitario de Valencia (Estimated) 05 07. This change likely represents an update in the location information related to the medical study being conducted at Hospital General Universitario de Valencia in Spain.
    Difference
    0.6%
    Check dated 2024-05-07T20:04:24.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:35:47.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.